Financial Challenges and Debt Management - The company may face challenges in generating sufficient cash flows to service its indebtedness, which could lead to the need for asset disposals or additional financing [175]. - The company has significant restrictions on its ability to incur additional indebtedness, which could limit its financial flexibility and increase risks associated with its current debt levels [174]. - The company's subsidiaries play a crucial role in its ability to repay debt, with potential regulatory restrictions impacting cash flow availability from certain subsidiaries, particularly those operating in China [179]. - The company has not paid dividends on its common stock since January 3, 1989, and current financing arrangements impose limitations on future dividend payments [183]. - The company's common stock is subordinate to all existing and future indebtedness, which may affect the recovery of common stockholders in the event of liquidation [186]. Market and Economic Risks - The market price of the company's common stock has been volatile, influenced by various factors including operating results and access to financial markets [181]. - Economic downturns and volatility in global markets could adversely affect the company's operations and financial condition, impacting customer demand and raw material availability [196]. - Changes in consumer preferences in the food and pet food industries could lead to reduced demand and price reductions for the company's products [203]. - Terrorist attacks or acts of war could disrupt operations and adversely affect net sales, costs, and financial condition [222]. - The UK’s withdrawal from the EU (Brexit) has created uncertainty that could adversely affect the company’s business and operations in Europe [232]. Regulatory and Compliance Issues - The company is subject to various governmental regulations across multiple jurisdictions, which could result in material costs and liabilities if compliance is not maintained [192]. - The company faces risks related to compliance with anti-bribery laws and regulations, particularly in international operations, which could lead to legal and reputational consequences [194]. - Compliance with evolving data privacy and cybersecurity laws, such as GDPR and CCPA, may require significant resources and could result in penalties for noncompliance [209][211]. - The company is subject to various lawsuits and regulatory proceedings that may materially affect business operations and financial condition, with potential costs being significant [217]. Operational and Strategic Risks - The company may face challenges in identifying and completing acquisitions on favorable terms, which could lead to unforeseen liabilities and operational difficulties [198]. - Future acquisitions could require the company to incur debt or assume contingent liabilities, potentially harming its business and financial results [198]. - Large capital projects, such as the DGD Joint Venture SAF project, may take years to complete, and changing market conditions could negatively impact expected returns [202]. - Disruptions in information systems could result in loss of sales and increased costs, adversely affecting the company's financial condition [204]. - The company may incur significant charges and experience disruptions if it closes or divests manufacturing plants or facilities [228]. Human Resources and Internal Controls - The company’s success is heavily reliant on key personnel, and challenges in attracting and retaining skilled employees could adversely affect operations [214]. - Potential material weaknesses in internal controls over financial reporting could harm public confidence and affect regulatory compliance [215]. Financial Instruments and Market Risks - The company has entered into interest rate swaps totaling a notional amount of $900.0 million, with a weighted average rate of 4.007% while receiving the 1-month SOFR rate, hedging variable rate debt into Q1 2026 [378]. - The aggregate fair value of the interest rate swaps as of December 28, 2024, was approximately $4.2 million [378]. - The company has also entered into cross currency swaps with a notional amount of €519.2 million, paying a 4.6% euro fixed rate while receiving a 5.799% U.S. dollar fixed rate, hedging intercompany notes receivable into Q1 2025 [379]. - The aggregate fair value of the cross currency swaps as of December 28, 2024, was approximately $22.2 million [379]. - The company has foreign exchange option and forward contracts considered cash flow hedges, with an aggregate fair value of approximately $32.6 million as of December 28, 2024 [380]. - Market risks include exposure to changes in prices of finished products, interest rates, availability of raw materials, and prices of natural gas and diesel fuel [375]. - The company makes limited use of derivative instruments for managing cash flow risks related to interest rates, natural gas, diesel fuel, inventory, forecasted sales, and foreign currency exchange rates [376]. - A 1% increase in interest rates is estimated to increase the Company's annual interest expense by approximately $9.6 million [387]. - The Company is exposed to currency fluctuations, particularly with respect to the euro, Brazilian real, Canadian dollar, Australian dollar, Chinese renminbi, Polish zloty, British pound, and Japanese yen [388]. Insurance and Pension Obligations - The company maintains insurance coverage that may not fully cover operational risks, and increases in claims or insurance premiums could adversely affect financial condition [219]. - European pension funds may require minimum funding contributions, with the IORP Directive II impacting the solvency requirements and potential delays in its review until 2025 [218]. Healthcare and Taxation Risks - Healthcare reform legislation in the U.S. could increase compensation costs and reduce net income, impacting cash flows [225]. - Changes in tax rates or exposure to additional income tax liabilities could adversely affect profitability, with potential impacts from differing statutory tax rates and changes in tax laws [216].
Darling Ingredients(DAR) - 2024 Q4 - Annual Report